This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Conley, J. Articles by Wong, J. P. Search for Related Content PubMed PubMed Citation Articles by Conley, J. Articles by Wong, J. P.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, 06 1997, 1288-1292, Vol 41, No. 6
Copyright © 1997 by the American Society for Microbiology. All rights reserved.

Aerosol delivery of liposome-encapsulated ciprofloxacin: aerosol characterization and efficacy against Francisella tularensis infection in mice

J Conley, H Yang, T Wilson, K Blasetti, V Di Ninno, G Schnell and JP Wong
SciLab Consulting Inc., Ralston, Alberta, Canada.

The aerosol delivery of liposome-encapsulated ciprofloxacin by using 12 commercially available jet nebulizers was evaluated in this study. Aerosol particles containing liposome-encapsulated ciprofloxacin generated by the nebulizers were analyzed with a laser aerodynamic particle sizer. Mean mass aerodynamic diameters (MMADs) and geometric standard deviations (GSDs) were determined, and the drug contents of the sampling filters from each run onto which aerosolized liposome- encapsulated ciprofloxacin had been deposited were analyzed spectrophotometrically. The aerosol particles of liposome-encapsulated ciprofloxacin generated by these nebulizers ranged from 1.94 to 3.5 microm, with GSDs ranging from 1.51 to 1.84 microm. The drug contents of the sampling filters exposed for 1 min to aerosolized liposome- encapsulated ciprofloxacin range from 12.7 to 40.5 microg/ml (0.06 to 0.2 mg/filter). By using the nebulizer selected on the basis of most desirable MMADs, particle counts, and drug deposition, aerosolized liposome-encapsulated ciprofloxacin was used for the treatment of mice infected with 10 times the 50% lethal dose of Francisella tularensis. All mice treated with aerosolized liposome-encapsulated ciprofloxacin survived the infection, while all ciprofloxacin-treated or untreated control mice succumbed to the infection (P < 0.001). These results suggest that aerosol delivery of liposome-encapsulated ciprofloxacin to the lower respiratory tract is feasible and that it may provide an effective therapy for the treatment of respiratory tract infections.

This article has been cited by other articles:

• Meers, P., Neville, M., Malinin, V., Scotto, A. W., Sardaryan, G., Kurumunda, R., Mackinson, C., James, G., Fisher, S., Perkins, W. R. (2008). Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections. J Antimicrob Chemother 61: 859-868 [Abstract] [Full Text]  
• LoBue, P. A. (2005). Inhaled Tobramycin: Not Just for Cystic Fibrosis Anymore?. Chest 127: 1098-1101 [Full Text]  
• Ellis, J., Oyston, P. C. F., Green, M., Titball, R. W. (2002). Tularemia. Clin. Microbiol. Rev. 15: 631-646 [Abstract] [Full Text]  
• Bakker-Woudenberg, I. A. J. M., ten Kate, M. T., Guo, L., Working, P., Mouton, J. W. (2002). Ciprofloxacin in Polyethylene Glycol-Coated Liposomes: Efficacy in Rat Models of Acute or Chronic Pseudomonas aeruginosa Infection. Antimicrob. Agents Chemother. 46: 2575-2581 [Abstract] [Full Text]  
• Bakker-Woudenberg, I. A. J. M., ten Kate, M. T., Guo, L., Working, P., Mouton, J. W. (2001). Improved Efficacy of Ciprofloxacin Administered in Polyethylene Glycol-Coated Liposomes for Treatment of Klebsiella pneumoniae Pneumonia in Rats. Antimicrob. Agents Chemother. 45: 1487-1492 [Abstract] [Full Text]